Effect of HIV-infection and cumulative viral load on age-related decline in grip strength

AIDS

Volumn 30, Issue 17, 2016, Pages 2645-2652

  Schrack, Jennifer A ^a   Jacobson, Lisa P ^a   Althoff, Keri N ^a   Erlandson, Kristine M ^b   Jamieson, Beth D ^c   Koletar, Susan L ^d   Phair, John ^e   Brown, Todd T ^f   Margolick, Joseph B ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Clinical weakness; Cumulative viral load; Functional decline; Grip strength

Indexed keywords

DIDANOSINE; EFAVIRENZ; STAVUDINE; ZIDOVUDINE;

ADULT; AGING; ARTICLE; COMORBIDITY; DETERIORATION; FEMALE; GRIP STRENGTH; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE EXPECTANCY; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; MONOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; VIRUS LOAD; AGED; CLINICAL TRIAL; HAND STRENGTH; LONGITUDINAL STUDY; MIDDLE AGED; MULTICENTER STUDY; MUSCLE STRENGTH; PATHOLOGY; QUESTIONNAIRE; VIROLOGY;

AGED; AGING; HAND STRENGTH; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MUSCLE STRENGTH; SURVEYS AND QUESTIONNAIRES; VIRAL LOAD;

EID: 84986203575     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000001245     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. HIV surveillance report, 2014, 26.2015.
2. Schrack JA, Althoff KN, Jacobson LP, Erlandson KM, Jamieson BD, Koletar SL, et al. Accelerated longitudinal gait speed decline in HIV-infected older men. J Acquir Immune Defic Syndr 2015; 70: 370-376.
3. Greene M, Covinsky K, Astemborski J, Piggott DA, Brown TT, Leng SX, et al. The relationship of physical performance with HIV disease and mortality. AIDS 2014; 28: 2711-2719.
4. Erlandson KM, Schrack JA, Jankowski CM, Brown TT, Campbell TB. Functional impairment, disability, and frailty in adults aging with HIV-infection. Curr HIV/AIDS Rep 2014; 11: 279-290.
5. BruunsgaardH, Pedersen BK. Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am 2003; 23: 15-39.
6. Althoff KN, McGinnis KA, Wyatt CM, Freiberg MS, Gilbert C, Oursler KK, et al. Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDSdefining cancer in HIV-infected versus uninfected adults. Clin Infect Dis 2015; 60: 627-638.
7. Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, et al. Closing the gap: Increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One 2013; 8: E81355.
8. Alley DE, Shardell MD, Peters KW, McLean RR, Dam TT, Kenny AM, et al. Grip strength cutpoints for the identification of clinically relevant weakness. J Gerontol A: Biol Sci Med Sci 2014; 69: 559-566.
9. Sayer AA, Kirkwood TB. Grip strength and mortality: A biomarker of ageing? Lancet 2015; 386: 226-227.
10. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998; 12: F51-F58.
11. ShahK,HiltonTN,MyersL,PintoJF,LuqueAE,HallWJ.Anewfrailty syndrome: Centralobesityandfrailty inolderadultswiththehuman immunodeficiency virus. J AmGeriatr Soc 2012; 60: 545-549.
12. Richert L, Brault M, Mercie P, Dauchy FA, Bruyand M, Greib C, et al. Handgrip strength is only weakly correlated with physical function in well controlled HIV infection: ANRS CO3 Aquitaine Cohort. J Acquir Immune Defic Syndr 2014; 65: E25-e27.
13. Raso V, Shephard RJ, do Rosario Casseb JS, da Silva Duarte AJ, D'Andrea Greve JM. Handgrip force offers a measure of physical function in individuals living with HIV/AIDS. J Acquir Immune Defic Syndr 2013; 63: E30-e32.
14. Erlandson KM, Allshouse AA, Jankowski CM, Lee EJ, Rufner KM, Palmer BE, et al. Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy. J Infect Dis 2013; 208: 249-259.
15. Dudley J, Jin S, Hoover D, Metz S, Thackeray R, Chmiel J. The Multicenter AIDS Cohort Study: Retention after 9 1/2 years.Am J Epidemiol 1995; 142: 323-330.
16. Ware JE Jr. SF-36 health survey update. Spine (Phila Pa 1976) 2000; 25: 3130-3139.
17. Hultin LE, Menendez FA, Hultin PM, Jamieson BD, O'Gorman MR, Borowski L, et al. Assessing immunophenotyping performance: Proficiency-validation for adopting improved flow cytometry methods. Cytometry B Clin Cytom 2007; 72: 249-255.
18. Department of Health and Human Services. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. http://www.aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf [Accessed on 31 August, 2014].
19. Centers for Disease Control and Prevention (CDC). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41: 1-19.
20. Cole SR, Napravnik S, Mugavero MJ, Lau B, Eron JJ Jr, Saag MS. Copy-years viremia as a measure of cumulative human immunodeficiency virus viral burden. Am J Epidemiol 2010; 171: 198-205.
21. Dodds RM, Syddall HE, Cooper R, Benzeval M, Deary IJ, Dennison EM, et al. Grip strength across the life course: Normative data from twelve British studies. PLoS One 2014; 9: E113637.
22. Cesari M, Penninx BWJH, Pahor M, Lauretani F, Corsi AM, Williams GR, et al. Inflammatory markers and physical performance in older persons: The InCHIANTI study. J Gerontol A Biol Sci Med Sci 2004; 59: M242-M248.
23. Federal Interagency Forum on Aging-Related Statistics. Older Americans 2012: Key indicators of well being.2012.
24. Frederiksen H, Hjelmborg J, Mortensen J, McGue M, Vaupel JW, Christensen K. Age trajectories of grip strength: Cross-sectional and longitudinal data among 8342 Danes aged 46 to 102. Ann Epidemiol 2006; 16: 554-562.
25. Althoff KN, Jacobson LP, Cranson R, Detels R, Phair J, Xiuhong L, et al. Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men. J Gerontol A Biol Sci Med Sci 2014; 69: 189-198.
26. Piggott DA, Muzaale AD, Mehta SH, Brown TT, Patel KV, Leng SX, et al. Frailty, HIV infection, and mortality in an aging cohort of injection drug users. PLoS One 2013; 8: E54910.
27. Oursler KK, Sorkin JD, Smith BA, Katzel LI. Reduced aerobic capacity and physical functioning in older HIV-infected men. AIDS Res Hum Retroviruses 2006; 22: 1113-1121.
28. Crawford KW, Li X, Xu X, Abraham AG, Dobs AS, Margolick JB, et al. Lipodystrophy and inflammation predict later grip strength in HIV-infected men: The MACS Body Composition substudy. AIDS Res Hum Retroviruses 2013; 29: 1138-1145.
29. Hartmann EL, Kitzman D, Rocco M, Leng X, Klepin H, Gordon M, et al. Physical function in older candidates for renal transplantation: An impaired population. Clin J Am Soc Nephrol 2009; 4: 588-594.
30. Center for Disease Control and Prevention. HIV among older Americans. CDC reports. 2013: November.